Revised global consensus statement on menopausal hormone therapy

T J de Villiers; J E Hall; J V Pinkerton; S Cerdas Pérez; M Rees; C Yang; D D Pierroz

doi:10.1016/j.maturitas.2016.06.001

Revised global consensus statement on menopausal hormone therapy

Maturitas. 2016 Sep:91:153-5. doi: 10.1016/j.maturitas.2016.06.001. Epub 2016 Jun 16.

Authors

T J de Villiers¹, J E Hall², J V Pinkerton³, S Cerdas Pérez⁴, M Rees⁵, C Yang⁶, D D Pierroz⁷

Affiliations

¹ Mediclinic Panorama and Department of Gynecology, University of Stellenbosch, Cape Town, Parow 7500, South Africa. Electronic address: tobie@iafrica.com.
² National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
³ Department of Obstetrics and Gynecology, The University of Virginia Health System, Charlottesville, VA, USA.
⁴ Endocrinology Department, Hospital Cima, San José, Costa Rica.
⁵ Reader Emeritus, University of Oxford, UK.
⁶ Mount Alvernia Hospital, Singapore.
⁷ University of Geneva, Switzerland.

PMID: 27389038
DOI: 10.1016/j.maturitas.2016.06.001

Abstract

The following Consensus Statement is endorsed by The International Menopause Society, The North American Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The Asia Pacific Menopause Federation, The International Osteoporosis Foundation and The Federation of Latin American Menopause Societies.

Publication types

Consensus Development Conference
Practice Guideline

MeSH terms

Estrogen Replacement Therapy*
Female
Global Health
Humans
Postmenopause*
Women's Health